• Pharma intelligence
• 08 Nov, 2018

The landscape of clinical trials continues to evolve over time as scientific breakthroughs and technological innovations emerge, which continue to be tracked by assessing recently initiated trials through Trialtrove’s annual Clinical Trials Roundup. Assessing the landscape of Phase I–III clinical trials that initiated in the previous year provides insights into competitive trial landscape, revealing priorities and strategies of the industry at large, as well as individual companies.
Read more...